94 results on '"Lolli, Marco Lucio"'
Search Results
2. Phenothiazines as anti-cancer agents: SAR overview and synthetic strategies
3. New aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the hydroxytriazole scaffold
4. Radiosynthesis of [18F]brequinar for in vivo PET imaging of hDHODH for potential studies of acute myeloid leukemia and cancers.
5. Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia
6. Potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: application of a bioisosteric scaffold hopping approach to flufenamic acid
7. Radiosynthesis of [18F]brequinar for in vivoPET imaging of hDHODH for potential studies of acute myeloid leukemia and cancersElectronic supplementary information (ESI) available. See DOI: https://doi.org/10.1039/d4md00433g
8. The Novel hDHODH Inhibitor MEDS433 Prevents Influenza Virus Replication by Blocking Pyrimidine Biosynthesis
9. Develop of new fluorescent probe to target hDHODH enzyme
10. Targeting Acute Myelogenous Leukemia using potent human dihydroorotate dehydrogenase inhibitors based on the 2-hydroxypyrazolo[1,5-a]pyridine scaffold: from academy to clinic
11. Important steps into drug development of MEDS433, a potent human dihydroorotate dehydrogenase inhibitor based on the 2-hydroxypyrazolo[1,5-a]pyridine scaffold
12. A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action
13. Searching for new NO-donor aspirin-like molecules: Furoxanylacyl derivatives of salicylic acid and related furazans
14. The Novel h DHODH Inhibitor MEDS433 Prevents Influenza Virus Replication by Blocking Pyrimidine Biosynthesis.
15. The New Generation hDHODH Inhibitor MEDS433 Hinders the In Vitro Replication of SARS-CoV-2 and Other Human Coronaviruses
16. Hydroxylated heterocycles as a bioisosteric tool to Modulate the carboxylic function into design potent human Dihydroorotate Dehydrogenase inhibitors
17. Targeting Myeloid Leukemias Using human Dihydroorotate Dehydrogenase Inhibitors Based on 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: Overcoming of Metabolic Issues
18. Improvement of Metabolic Weakness of New Dihydroorotate Dehydrogenase Inhibitors Based on 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold to Target Myeloid Leukemias
19. The inhibition of human DHODH by M433 leads to differentiation and apoptosis in acute myeloid leukemia
20. Apoptotic and differentiating therapy for AML using potent human dihydroorotate dehydrogenase inhibitor
21. Inibitori della diidroorotato deidrogenasi umana (hDHODH) per l'uso come antivirali
22. The Synergism between DHODH Inhibitors and Dipyridamole Leads to Metabolic Lethality in Acute Myeloid Leukemia
23. The new generation hDHODH inhibitor MEDS433 hinders thein vitroreplication of SARS-CoV-2
24. The Synergism Between DHODH Inhibitors and Dipyridamole Leads to Metabolic Lethality in Acute Myeloid Leukemia
25. Multiple catalytic activities of human 17β-hydroxysteroid dehydrogenase type 7 respond differently to inhibitors
26. Synthesis, physiochemical proprieties and application of hydroxyazole systems as carboxylic acid isoster
27. Design, synthesis and co-crystallization of new Plasmodium falciparum dihydroorotate dehydrogenase inhibitors based on hydroxypyrazole scaffold
28. Synthesis of [18F] Brequinar as PET Imaging probes for human dihydroorotate dehydrogenase
29. NOVEL HUMAN DIHYDROOROTATE DEHYDROGENASE (HDHODH) INHIBITORS AND THEIR USE IN TARGETING ONCOLOGICAL DISEASES SENSITIVE TO PYRIMIDINE STARVATION
30. A differentiating and apoptotic therapy for acute myeloid leukaemia using potent human dihydroorotate dehydrogenase inhibitors
31. Application of an in house bioisosteric approach to the design of innovative inhibitors of aldo-keto reductase 1C3 (AKR1C3)
32. Preliminary ADME/PK studies of new hDHODH inhibitors effective for treatment of acute myeloid leukaemia (AML)
33. New human dihydroorotate dehydrogenase inhibitors able to restore myeloid differentiation in AML
34. Nuovi inibitori della diidroorotato deidrogenasi umana (hDHODH) e loro uso mirato sul differenziamento mieloide
35. In vitro myeloid differentiation using a new generation of potent human dihydroorotate dehydrogenase (hDHODH) inhibitors
36. Towards high relaxivity: a new series of Gadolinium complexes with improved prototropic exchange effect for magnetic resonance imaging
37. Meds433, a New Dihydroorotate Dehydrogenase Inhibitor, Induces Apoptosis and Differentiation in Acute Myeloid Leukemia
38. SYNTHESIS OF NEW GADOLINIUM COMPLEXES FOR MAGNETIC RESONANCE IMAGING WITH IMPROVED RELAXIVITY
39. Exploring the intramolecular catalysis of the proton exchange process to modulate the relaxivity of Gd(iii)-complexes of HP-DO3A-like ligands
40. Targeting the human Dihydroorotate Dehydrogenase (hDHODH) by a Scaffold Hopping Bioisosteric approach using Hydroxylated Pentatomic Heterocycles
41. SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF NOVEL AMINO BIOISOSTERES FOR THE GABAa RECEPTOR
42. SUBSTITUTED 4-HYDROXY-1H-1,2,3-TRIAZOLES: SYNTHESIS AND BIOISOSTERIC APPLICATIONS
43. Probing salicylamide bioisosteric replacement in the design of Plasmodium Falciparum dihydroorotate dehydrogenase (pfDHODH) inhibitors
44. 1,2,5-Oxadiazole analogues of leflunomide and related compounds
45. Hydroxy-1,2,5-oxadiazolyl moiety as bioisoster of the carboxy function. Sunthesis, ionization constants, and pharmacological characterisation of gamma-aminobutyric acid (GABA) related compounds
46. NEW CLASS OF NO-DONORS WITH BONE SELECTIVITY
47. New NO-donor Bisphosphonates
48. Synthesis of labelled [N-15(3)]-6-bromopurine, a useful precursor of N-15-labelled O-6-alkylguanines, to be used as internal standards for quantitative GC-MS analyses
49. STUDIES ON AGENTS WITH MIXED NO-DEPENDENT VASODILATING AND β-BLOCKING ACTIVITIES
50. Unsymmetrically substituted furoxants. 17. Structural investigations in benzenesulfonylfuroxan derivatives and related compounds
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.